[
    {
        "Type of cases ": "NSP Cured",
        "I Qtr-2022": "203",
        "II Qtr-2022": "159",
        "III Qtr-2022": "217",
        "IV Qtr-2022": "181",
        "Total 2022": "760",
        "%": "82.4"
    },
    {
        "Type of cases ": "NSP Treatment completed",
        "I Qtr-2022": "0",
        "II Qtr-2022": "2",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "2",
        "%": "0.2"
    },
    {
        "Type of cases ": "NSP Died",
        "I Qtr-2022": "7",
        "II Qtr-2022": "3",
        "III Qtr-2022": "10",
        "IV Qtr-2022": "13",
        "Total 2022": "33",
        "%": "3.6"
    },
    {
        "Type of cases ": "NSP Failure",
        "I Qtr-2022": "4",
        "II Qtr-2022": "5",
        "III Qtr-2022": "7",
        "IV Qtr-2022": "4",
        "Total 2022": "20",
        "%": "2.2"
    },
    {
        "Type of cases ": "NSP Lost to Follow-up",
        "I Qtr-2022": "7",
        "II Qtr-2022": "6",
        "III Qtr-2022": "3",
        "IV Qtr-2022": "7",
        "Total 2022": "23",
        "%": "2.5"
    },
    {
        "Type of cases ": "NSP Not Evaluated",
        "I Qtr-2022": "1",
        "II Qtr-2022": "3",
        "III Qtr-2022": "1",
        "IV Qtr-2022": "1",
        "Total 2022": "6",
        "%": "0.7"
    },
    {
        "Type of cases ": "NSP Treatment Regimen Changed",
        "I Qtr-2022": "24",
        "II Qtr-2022": "17",
        "III Qtr-2022": "23",
        "IV Qtr-2022": "14",
        "Total 2022": "78",
        "%": "8.5"
    },
    {
        "Type of cases ": "NSP Total",
        "I Qtr-2022": "246",
        "II Qtr-2022": "195",
        "III Qtr-2022": "261",
        "IV Qtr-2022": "220",
        "Total 2022": "922",
        "%": ""
    },
    {
        "Type of cases ": "NSN/NEP Cured",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "NSN/NEP Treatment completed",
        "I Qtr-2022": "453",
        "II Qtr-2022": "340",
        "III Qtr-2022": "472",
        "IV Qtr-2022": "395",
        "Total 2022": "1660",
        "%": "96.1"
    },
    {
        "Type of cases ": "NSN/NEP Died",
        "I Qtr-2022": "2",
        "II Qtr-2022": "9",
        "III Qtr-2022": "7",
        "IV Qtr-2022": "7",
        "Total 2022": "25",
        "%": "1.4"
    },
    {
        "Type of cases ": "NSN/NEP Failure",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "NSN/NEP Lost to Follow-up",
        "I Qtr-2022": "9",
        "II Qtr-2022": "3",
        "III Qtr-2022": "8",
        "IV Qtr-2022": "14",
        "Total 2022": "34",
        "%": "2"
    },
    {
        "Type of cases ": "NSN/NEP Not Evaluated",
        "I Qtr-2022": "4",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "4",
        "%": "0.2"
    },
    {
        "Type of cases ": "NSN/NEP Treatment Regimen Changed",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "4",
        "IV Qtr-2022": "1",
        "Total 2022": "5",
        "%": "0.3"
    },
    {
        "Type of cases ": "NSN/NEP Total",
        "I Qtr-2022": "468",
        "II Qtr-2022": "352",
        "III Qtr-2022": "491",
        "IV Qtr-2022": "417",
        "Total 2022": "1728",
        "%": ""
    },
    {
        "Type of cases ": "RT +ve Cured",
        "I Qtr-2022": "53",
        "II Qtr-2022": "56",
        "III Qtr-2022": "54",
        "IV Qtr-2022": "52",
        "Total 2022": "215",
        "%": "75.2"
    },
    {
        "Type of cases ": "RT+ve Treatment completed",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "RT +Ve Died",
        "I Qtr-2022": "4",
        "II Qtr-2022": "7",
        "III Qtr-2022": "5",
        "IV Qtr-2022": "5",
        "Total 2022": "21",
        "%": "7.3"
    },
    {
        "Type of cases ": "RT +ve Failure",
        "I Qtr-2022": "2",
        "II Qtr-2022": "0",
        "III Qtr-2022": "1",
        "IV Qtr-2022": "3",
        "Total 2022": "6",
        "%": "2.1"
    },
    {
        "Type of cases ": "RT +ve Lost to Follow-up",
        "I Qtr-2022": "3",
        "II Qtr-2022": "1",
        "III Qtr-2022": "4",
        "IV Qtr-2022": "7",
        "Total 2022": "15",
        "%": "5.2"
    },
    {
        "Type of cases ": "RT +ve Not Evaluated",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "RT +ve Treatment Regimen Changed",
        "I Qtr-2022": "3",
        "II Qtr-2022": "9",
        "III Qtr-2022": "8",
        "IV Qtr-2022": "9",
        "Total 2022": "29",
        "%": "10"
    },
    {
        "Type of cases ": "RT +ve Total",
        "I Qtr-2022": "65",
        "II Qtr-2022": "73",
        "III Qtr-2022": "72",
        "IV Qtr-2022": "76",
        "Total 2022": "286",
        "%": ""
    },
    {
        "Type of cases ": "RT Neg Cured",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "RT Neg Treatment completed",
        "I Qtr-2022": "62",
        "II Qtr-2022": "37",
        "III Qtr-2022": "73",
        "IV Qtr-2022": "54",
        "Total 2022": "226",
        "%": "92.6"
    },
    {
        "Type of cases ": "RT Neg Died",
        "I Qtr-2022": "1",
        "II Qtr-2022": "0",
        "III Qtr-2022": "3",
        "IV Qtr-2022": "3",
        "Total 2022": "7",
        "%": "2.9"
    },
    {
        "Type of cases ": "RT Neg Failure",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "RT Neg Lost to Follow-up",
        "I Qtr-2022": "4",
        "II Qtr-2022": "3",
        "III Qtr-2022": "3",
        "IV Qtr-2022": "1",
        "Total 2022": "11",
        "%": "4.5"
    },
    {
        "Type of cases ": "RT Neg Not Evaluated",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "RT Neg Treatment Regimen Changed",
        "I Qtr-2022": "0",
        "II Qtr-2022": "0",
        "III Qtr-2022": "0",
        "IV Qtr-2022": "0",
        "Total 2022": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "RT Neg Total",
        "I Qtr-2022": "67",
        "II Qtr-2022": "40",
        "III Qtr-2022": "79",
        "IV Qtr-2022": "58",
        "Total 2022": "244",
        "%": ""
    }
]